Literature DB >> 25559601

Impact of hepatitis coinfection on healthcare utilization among persons living with HIV.

Trevor A Crowell1, Stephen A Berry, John A Fleishman, Richard W LaRue, Philip T Korthuis, Ank E Nijhawan, Richard D Moore, Kelly A Gebo.   

Abstract

: Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection are increasingly important sources of morbidity among HIV-infected persons. We determined associations between hepatitis coinfection and healthcare utilization among HIV-infected adults at 4 US sites during 2006-2011. Outpatient HIV visits did not differ by hepatitis serostatus and decreased over time. Mental health visits were more common among HIV/HCV coinfected persons than among HIV monoinfected persons [incidence rate ratio (IRR): 1.27, 95% confidence interval (CI): 1.08 to 1.50]. Hospitalization rates were higher among all hepatitis-infected groups than among HIV monoinfected (HIV/HBV: IRR: 1.23, 95% CI: 1.05 to 1.44; HIV/HCV: IRR: 1.22, 95% CI: 1.10 to 1.36; HIV/HBV/HCV: IRR: 1.31, 95% CI: 1.02 to 1.68). These findings may inform the design of clinical services and allocation of resources.

Entities:  

Mesh:

Year:  2015        PMID: 25559601      PMCID: PMC4336227          DOI: 10.1097/QAI.0000000000000490

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  36 in total

1.  Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.

Authors:  Colette Smith; Caroline A Sabin; Jens D Lundgren; Rodolphe Thiebaut; Rainer Weber; Matthew Law; Antonella d'Arminio Monforte; Ole Kirk; Nina Friis-Moller; Andrew Phillips; Peter Reiss; Wafaa El Sadr; Christian Pradier; Signe W Worm
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

2.  HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study.

Authors:  Rainer Weber; Caroline Sabin; Peter Reiss; Stephane de Wit; Signe W Worm; Matthew Law; Francois Dabis; Antonella D'Arminio Monforte; Eric Fontas; Wafaa El-Sadr; Ole Kirk; Martin Rickenbach; Andrew Phillips; Bruno Ledergerber; Jens Lundgren
Journal:  Antivir Ther       Date:  2010

3.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

4.  Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007.

Authors:  C Vellozzi; K Buchacz; R Baker; P R Spradling; J Richardson; A Moorman; E Tedaldi; M Durham; J Ward; J T Brooks
Journal:  J Viral Hepat       Date:  2011-05       Impact factor: 3.728

5.  Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication.

Authors:  Philip S Wang; Michael Lane; Mark Olfson; Harold A Pincus; Kenneth B Wells; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection.

Authors:  Sanjaya Kumar Satapathy; Chandra Sekhar Lingisetty; Susan Williams
Journal:  Hepatol Int       Date:  2011-06-23       Impact factor: 6.047

7.  Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?

Authors:  Howard B Gale; Steven R Gitterman; Heather J Hoffman; Fred M Gordin; Debra A Benator; Ann M Labriola; Virginia L Kan
Journal:  Clin Infect Dis       Date:  2013-01-11       Impact factor: 9.079

8.  HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.

Authors:  D Lincoln; K Petoumenos; G J Dore
Journal:  HIV Med       Date:  2003-07       Impact factor: 3.180

9.  Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America.

Authors:  Judith A Aberg; Joel E Gallant; Khalil G Ghanem; Patricia Emmanuel; Barry S Zingman; Michael A Horberg
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

10.  Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population.

Authors:  John D Scott; Anna Wald; Mari Kitahata; Elizabeth Krantz; Linda Drolette; Lawrence Corey; Chia C Wang
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

View more
  16 in total

Review 1.  HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.

Authors:  Kasha P Singh; Megan Crane; Jennifer Audsley; Anchalee Avihingsanon; Joe Sasadeusz; Sharon R Lewin
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

2.  Prospective association of social circumstance, socioeconomic, lifestyle and mental health factors with subsequent hospitalisation over 6-7 year follow up in people living with HIV.

Authors:  Sophia M Rein; Colette J Smith; Clinton Chaloner; Adam Stafford; Alison J Rodger; Margaret A Johnson; Jeffrey McDonnell; Fiona Burns; Sara Madge; Alec Miners; Lorraine Sherr; Simon Collins; Andrew Speakman; Andrew N Phillips; Fiona C Lampe
Journal:  EClinicalMedicine       Date:  2020-12-01

Review 3.  A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science.

Authors:  Allison R Webel; Julie Schexnayder; Patricia A Cioe; Julie A Zuñiga
Journal:  J Assoc Nurses AIDS Care       Date:  2021 May-Jun 01       Impact factor: 1.809

4.  Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.

Authors:  Carmine Rossi; Janet Raboud; Sharon Walmsley; Curtis Cooper; Tony Antoniou; Ann N Burchell; Mark Hull; Jason Chia; Robert S Hogg; Erica E M Moodie; Marina B Klein
Journal:  BMC Infect Dis       Date:  2017-04-04       Impact factor: 3.090

5.  Predictors of Missed Hepatitis C Intake Appointments and Failure to Establish Hepatitis C Care Among Patients Living With HIV.

Authors:  Edward R Cachay; Lucas Hill; Francesca Torriani; Craig Ballard; David Grelotti; Abigail Aquino; W Christopher Mathews
Journal:  Open Forum Infect Dis       Date:  2018-07-31       Impact factor: 3.835

6.  Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: a cross sectional study in Abuja and Lagos, Nigeria.

Authors:  Olusegun A Adeyemi; Andrew Mitchell; Ashley Shutt; Trevor A Crowell; Nicaise Ndembi; Afoke Kokogho; Habib O Ramadhani; Merlin L Robb; Stefan D Baral; Julie A Ake; Manhattan E Charurat; Sheila Peel; Rebecca G Nowak
Journal:  BMC Infect Dis       Date:  2021-07-06       Impact factor: 3.090

7.  Hepatitis and tuberculosis testing are much less common than HIV testing among adults in Kisumu, Kenya: results from a cross-sectional assessment.

Authors:  Joshua Tunnage; Adam Yates; Chiaka Nwoga; Valentine Sing'oei; John Owuoth; Christina S Polyak; Trevor A Crowell
Journal:  BMC Public Health       Date:  2021-06-15       Impact factor: 3.295

8.  Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study.

Authors:  Trevor A Crowell; Anuradha Ganesan; Stephen A Berry; Robert G Deiss; Brian K Agan; Jason F Okulicz
Journal:  J Int AIDS Soc       Date:  2016-03-07       Impact factor: 5.396

Review 9.  Development of peptide inhibitors of HIV transmission.

Authors:  Siyu Shi; Peter K Nguyen; Henry J Cabral; Ramon Diez-Barroso; Paul J Derry; Satoko M Kanahara; Vivek A Kumar
Journal:  Bioact Mater       Date:  2016-09-16

10.  The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study.

Authors:  Huiting Ma; Conrado Franco Villalobos; Martin St-Jean; Oghenowede Eyawo; Miriam Ruth Lavergne; Lianping Ti; Mark W Hull; Benita Yip; Lang Wu; Robert S Hogg; Rolando Barrios; Jean A Shoveller; Julio S G Montaner; Viviane D Lima
Journal:  BMC Health Serv Res       Date:  2018-05-02       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.